All stocks Β· TARSONS
TP

Tarsons Products Limited

TARSONS BSE Medical Instruments & Supplies Healthcare

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, cla…

ISIN INE144Z01023
Listed β€”
Quarters tracked 13
Filings 10 docs

About

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables. It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.

Key Metrics

as of Sep 2026
Market Cap1,782 Cr
P/E150.00
Div Yield0.00 %
Book Valueβ‚Ή119.00
52w Highβ‚Ή375.00
52w Lowβ‚Ή164.00
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 86.15 97.16 83.99 80.51 71.28 93.04 76.16 80.12 64.85 86.64 61.79 66.32 62.57
Expenses 61.98 64.59 54.85 54.37 49.05 56.07 48.24 56.62 47.83 52.77 38.90 40.94 41.27
Operating Profit 24.17 32.57 29.14 26.14 22.23 36.97 27.92 23.50 17.02 33.87 22.89 25.38 21.30
OPM % 28.06 33.52 34.69 32.47 31.19 39.74 36.66 29.33 26.25 39.09 37.04 38.27 34.04
Other Income 6.75 7.64 8.36 7.32 4.58 6.37 2.12 10.65 4.86 5.93 3.38 2.60 2.26
Depreciation 24.56 26.70 22.65 20.17 17.75 17.48 15.61 11.96 8.96 10.21 10.06 9.71 8.30
Interest 5.44 5.41 5.32 4.41 4.28 4.52 4.13 4.68 4.20 4.08 2.51 0.95 2.41
Profit before tax 0.92 8.10 9.53 8.88 4.78 21.34 10.30 17.51 8.72 25.51 13.70 17.32 12.85
Tax % 26.09 32.59 25.60 26.46 25.10 26.34 26.12 26.21 25.80 26.34 26.42 26.10 25.29
Net Profit 0.68 5.46 7.09 6.53 3.57 15.73 7.61 12.93 6.46 18.78 10.07 12.80 9.60
EPS in Rs 0.13 1.03 1.33 1.23 0.67 2.96 1.43 2.43 1.21 3.53 1.89 2.41 1.80

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 333.00314.00277.00283.00301.00229.00176.00179.00
Expenses 223.00209.00174.00153.00148.00125.00107.00107.00
Operating Profit 110.00105.00103.00130.00153.00103.0069.0072.00
OPM % 33.0034.0037.0046.0051.0045.0039.0040.00
Other Income 28.0024.0014.0012.008.005.004.006.00
Interest 19.0018.0010.004.004.003.006.007.00
Depreciation 87.0054.0038.0029.0022.0014.0014.0015.00
Profit before tax 31.0058.0069.00109.00135.0092.0053.0056.00
Tax % 28.0026.0026.0026.0025.0025.0024.0030.00
Net Profit 23.0043.0051.0081.00101.0069.0041.0039.00
EPS in Rs 4.268.039.6315.1718.923,583.252,108.742,027.06
Dividend Payout % 0.000.0021.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 11.0011.0011.0011.0011.000.190.200.19
Reserves 665.00642.00610.00559.00479.00244.00197.00135.00
Borrowings 274.00231.00257.00111.0022.0034.0036.0065.00
Other Liabilities 152.00107.0076.0046.0033.0018.0015.0012.00
Total Liabilities 1,102.00991.00953.00726.00544.00296.00249.00212.00
Fixed Assets 661.00460.00252.00225.00189.00120.0092.0089.00
CWIP 159.00233.00267.00119.0032.0022.0019.007.00
Investments 44.0013.000.000.000.000.000.000.00
Other Assets 238.00285.00434.00382.00323.00153.00137.00116.00
Total Assets 1,102.00991.00953.00726.00544.00296.00249.00212.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity 112.00110.00105.0076.0083.0068.0064.0051.00
Cash from Investing Activity -138.00-52.00-296.00-179.00-138.00-64.00-26.00-34.00
Cash from Financing Activity 25.00-54.00136.0085.00130.00-27.00-14.00-18.00
Net Cash Flow -1.004.00-55.00-18.0075.00-23.0025.000.00
Free Cash Flow -14.00-42.00-79.00-113.00-48.006.0038.0018.00
CFO/OP % 109.00120.00119.0077.0077.0089.00115.0095.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 85.0086.0094.0085.0079.0075.0079.0091.00
Inventory Days 387.00419.00528.00642.00478.00277.00365.00333.00
Days Payable 48.0036.0042.0054.0075.0035.0044.0014.00
Cash Conversion Cycle 423.00469.00580.00672.00482.00317.00400.00409.00
Working Capital Days -30.0037.00-24.00166.00150.00108.00110.0086.00
ROCE % 6.009.0010.0019.0035.0037.0027.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 47.30 47.30 47.30 47.31 47.31 47.31 47.31 47.31 47.31 47.31 47.31 47.31
FIIs 0.15 0.87 2.46 5.82 9.14 9.53 7.51 8.04 7.95 8.16 6.83 7.85
DIIs 0.10 0.19 0.00 0.08 0.04 0.30 0.51 0.21 0.11 0.17 2.60 3.15
Public 52.44 51.65 50.23 46.79 43.50 42.89 44.69 44.45 44.63 44.36 43.27 41.68
No. of Shareholders 83,453 84,093 87,336 88,966 90,891 93,417 96,927 99,586 105,330 102,866 107,564 108,236

Corporate Actions

3 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 20 Sep 2024 β€” β€” 2.00
Other 07 Jul 2023 β€” β€” β€” Annual General Meeting
Other 21 Jul 2022 β€” β€” β€” Annual General Meeting

Announcements

5 filings